Latest news
Loading news…
Adrestia is developing therapeutics that work in an entirely new way – restoring the biological balance in damaged, diseased or dying cells
Adrestia Therapeutics was acquired by Insmed in 2023.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
5
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- Babraham, Cambridgeshire, United Kingdom
Key People at Adrestia Therapeutics
CEO
Chief R&D Officer
Founder and VP Research Head
Founder, Chief Executive and Chief Scientific Officer
5
professional contacts at Adrestia Therapeutics
Contact execs at Adrestia Therapeutics →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Adrestia Therapeutics
Loading news…
FAQs about Adrestia Therapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.